Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Orphan Drug Development of paquinimod for the treatment of Systemic Sclerosis

Reference number
Coordinator ACTIVE Biotech AB
Funding from Vinnova SEK 45 000
Project duration September 2011 - November 2011
Status Completed

Last updated 25 November 2019

Reference number 2011-03325

Page statistics